News
2025
April 21, 2025
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
VIEW PRESS RELEASEMarch 7, 2025
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
VIEW PRESS RELEASEMarch 1, 2025
Sonendo, Inc. Announces $5.0 Million Private Placement
VIEW PRESS RELEASEJanuary 13, 2025
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
VIEW PRESS RELEASE2024
December 24, 2024
OS Therapies Announces Pricing of $6 Million Private Placement
VIEW PRESS RELEASEDecember 24, 2024
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
VIEW PRESS RELEASEDecember 23, 2024
MAXONA Pharmaceuticals Closes on $6,960,500 Series B Convertible Preferred Stock Offering
VIEW PRESS RELEASEDecember 19, 2024
Marker Therapeutics Announces $16.1 Million Private Placement
VIEW PRESS RELEASENovember 21, 2024
Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement
VIEW PRESS RELEASE2023
December 27, 2023
Media and entertainment SPAC Iron Horse Acquisitions prices upsized $61 million IPO
VIEW PRESS RELEASENovember 10, 2023
AI Transportation Acquisition Corp Announces Pricing Of $60,000,000 Initial Public Offering
VIEW PRESS RELEASEOctober 31, 2023
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
VIEW PRESS RELEASEOctober 11, 2023
Quetta Acquisition Corporation Announces Closing of $69 Million Initial Public Offering
VIEW PRESS RELEASEOctober 2, 2023
SAB Biotherapeutics Announces Private Placement of up to $130 Million to Advance Development of Lead Drug Candidate for Type 1 Diabetes
VIEW PRESS RELEASE2022
December 23, 2022
IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
VIEW PRESS RELEASEDecember 23, 2022
Outlook Therapeutics® Enters Definitive Agreement for $31.8 Million Unsecured Convertible Promissory Note
VIEW PRESS RELEASEDecember 7, 2022
X4 Pharmaceuticals Prices $65.0 Million Public Offering
VIEW PRESS RELEASEDecember 7, 2022
SAB Biotherapeutics Announces $7.9 Million Private Placement of Common Stock
VIEW PRESS RELEASENovember 30, 2022
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
VIEW PRESS RELEASE2021
December 21, 2021
Larkspur Health Acquisition Corp. Prices $75 Million Initial Public Offering
VIEW PRESS RELEASEDecember 15, 2021
Ault Disruptive Technologies Corporation Prices $100 Million Initial Public Offering
VIEW PRESS RELEASEDecember 13, 2021
IceCure Medical LTD. Closes $17 Million Underwritten Public Offering
VIEW PRESS RELEASEDecember 13, 2021
Alpha Star Acquisition Prices $100M IPO
VIEW PRESS RELEASEDecember 08, 2021
Inception Growth Acquisition Limited Announces Pricing of $90,000,000 Initial Public Offering
VIEW PRESS RELEASE2020
July 31, 2020
FSD Pharma Inc. Announces US $10 Million Registered Direct Offering
VIEW PRESS RELEASEJuly 29, 2020
Arcturus Therapeutics Announces Pricing of $173 Million Public Offering of Common Stock
VIEW PRESS RELEASEJuly 22, 2020
Genocea Announces Private Placement Financing of Up to $80 Million
VIEW PRESS RELEASEJuly 22, 2020
CASI Pharmaceuticals Announces Pricing of $38 Million Public Offering of Common Stock
VIEW PRESS RELEASEJuly 16, 2020
Atreca, Inc. Announces Pricing of Underwritten Public Offering of Common Stock
VIEW PRESS RELEASE2019
December 23, 2019
Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock
VIEW PRESS RELEASEDecember 12, 2019
SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants
VIEW PRESS RELEASEOctober 22, 2019
Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering
VIEW PRESS RELEASESeptember 26, 2019
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
VIEW PRESS RELEASEAugust 6, 2019
BioCardia Announces Closing of $10.0 Million Public Offering
VIEW PRESS RELEASE
